Current Practice of Hypertension in India: Focus on Blood Pressure Goals

Current Practice of Hypertension in India: Focus on Blood Pressure Goals

Introduction: Recommended Blood Pressure (BP) goals in elderly and those with co-morbid conditions like Diabetes Mellitus (DM) and Chronic Kidney Disease (CKD) vary in different Hypertension (HTN) management guidelines. Aim: To understand currently followed BP goals and practices among the phys...

Full description

Bibliographic Details
Main Authors:	Jagdish S. Hiremath, Vijay M. Katekhaye, Vijay S. Chamle, Rishi M. Jain, Amit I. Bhargava
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2016-12-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	ambulatory blood pressure monitoring beta blocker diabetes hypertension guidelines
Online Access:	https://jcdr.net/articles/PDF/8999/21783_CE[Ra]_F(DK)_PF1(PI_RK)_PFA(AK)_PF2(PAG).pdf

Similar Items

The role of beta-blockers in the treatment of hypertension in 2018 ESC/ESH guidelines
by: A. O. Konradi, et al.
Published: (2018-12-01)

ROLE OF BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION TREATMENT. WHAT DO EVIDENCE BASED MEDICINE DATA SHOW?
by: S. Y. Martsevich
Published: (2016-01-01)

Hypertension on Target with TENORMIN (HOTT) Study-Evaluation of the Effectiveness and Safety of Atenolol in Indian Population
by: Qayum Mukaddam, et al.
Published: (2014-01-01)

Management of Hypertensive Crises in Children: A Review of the Recent Literature
by: Nicola Bertazza Partigiani, et al.
Published: (2022-04-01)

THE ROLE OF VASODILATING BETA-BLOCKERS IN PATIENTS WITH HYPERTENSION AND THE CARDIOMETABOLIC SYNDROME
by: A. A. Taylor, et al.
Published: (2011-08-01)

Prevalence of sympathetic overactivity in hypertensive patients – A pan India, non-interventional, cross sectional study
by: T.N.C. Padmanabhan, et al.
Published: (2014-11-01)

Prospective follow-up of nebivolol in the treatment of arterial hypertension
by: Despotović Nebojša, et al.
Published: (2012-01-01)

Impact of 2018 ESC/ESH and 2017 ACC/AHA Hypertension Guidelines: Difference in Prevalence of White-Coat and Masked Hypertension
by: Byong-Kyu Kim, et al.
Published: (2020-05-01)

Trends of antihypertensive use among patients with cancer and hypertension in the United States 2002–2019
by: Harshith Thyagaturu, et al.
Published: (2023-09-01)

Association of Hypertension and Breast Cancer: Antihypertensive Drugs as an Effective Adjunctive in Breast Cancer Therapy
by: Fan Y, et al.
Published: (2022-04-01)

Short Term Safety and Tolerability of a Fixed Dose Combination of Olmesartan, Amlodipine and Hydrochlorothiazide
by: J. C. Mohan, et al.
Published: (2015-08-01)

NEBIVOLOL: A THIRD GENERATION BETA BLOCKER AS ANTIHYPERTENSION AGENT
by: Ni Putu Wirantari, et al.
Published: (2013-07-01)

Treatment of Hypertension in Renal Transplant Recipients in Four Independent Cross-Sectional Analyses
by: Izabella Kuźmiuk-Glembin, et al.
Published: (2018-01-01)

Management of Hypertension with Female Sexual Dysfunction
by: Qing Zhong, et al.
Published: (2022-05-01)

The association of exaggerated hypertensive response to exercise and beta-blockers use in hypertensives
by: Kadir Uğur Mert, et al.
Published: (2020-11-01)

Cost-effectiveness of hypertension treatment: a population-based study
by: Juvenal Soares Dias da Costa, et al.

BISOPROLOL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH CARDIOPULMONARY DISEASES
by: G. N. Gorokchovskaya, et al.
Published: (2016-01-01)

New targets and old therapies for arterial hypertension
by: S. R. Gilyarevsky, et al.
Published: (2019-04-01)

Impacto na reclassificação da hipertensão pela Monitorização Ambulatorial da Pressão Arterial (MAPA) segundo a V Diretriz Brasileira de MAPA Impact on hypertension reclassification by Ambulatory Blood Pressure Monitoring (ABPM) according to the V Brazilian Guidelines on ABPM
by: Daniel Forestiero, et al.
Published: (2013-02-01)

The Pharmacogenomics of Anti-Hypertensive Therapy
by: Sandosh Padmanabhan, et al.
Published: (2010-06-01)

TREATMENT OF HYPERTENSION IN PREGNANCY: GUIDELINES AND CLINICAL EXPERIENCE
by: O. V. Gaisenok, et al.
Published: (2015-09-01)

Arterial hypertension: modern advances in metabolomics
by: S. K. Zyryanov, et al.
Published: (2021-10-01)

Heart rate in patients with or without hypertension: A retrospective study
by: Shankar G Vasista
Published: (2020-01-01)

Effects of Nebivolol therapy on hemodynamic parameters and lipid profile compared to other beta blockers in patients with essential hypertension: a systematic review and meta-analysis
by: I Made Fermi Wikananda, et al.
Published: (2024-01-01)

Antihypertensive efficacy of metoprolol XL/Low dose chlorthalidone (6.25 mg) combination: a randomized, comparative study in Indian patients with mild-to-moderate essential hypertension
by: Pareek A, et al.
Published: (2009-07-01)

Effect of Fimasartan versus Valsartan and Olmesartan on Office and Ambulatory Blood Pressure in Korean Patients with Mild-to-Moderate Essential Hypertension: A Randomized, Double-Blind, Active Control, Three-Parallel Group, Forced Titration, Multicenter, Phase IV Study (Fimasartan Achieving Systolic Blood Pressure Target (FAST) Study)
by: Chung WB, et al.
Published: (2020-01-01)

COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Hypertension and COVID-19: Potential use of beta-blockers and a call for randomized evidence
by: Mochamad Yusuf Alsagaff, et al.
Published: (2021-11-01)

Hepatic venous pressure gradient measurement guiding nonselective beta‐blocker therapy in a patient with clinically significant portal hypertension
by: Kun Wang, et al.
Published: (2023-06-01)

COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Predictive Model for Ambulatory Hypertension Based on Office Blood Pressure in Obese Children
by: Girish C. Bhatt, et al.
Published: (2020-05-01)

Blood Pressure Control Goals in Elderly Patients with Hypertension：Evidence from Latest Clinical Studies
by: LIU Kaixuan, GUO Yifang
Published: (2022-04-01)

BLOOD PRESSURE PHENOTYPES IN TREATED HYPERTENSIVE PATIENTS IN SUMMER AND WINTER: FOCUS ON MASKED UNCONTROLLED HYPERTENSION. PART 1: BLOOD PRESSURE PHENOTYPES PREVALENCE
by: M. I. Smirnova, et al.
Published: (2017-11-01)

Exploring Sex Differences of Beta-Blockers in the Treatment of Hypertension: A Systematic Review and Meta-Analysis
by: Nick Wilmes, et al.
Published: (2023-05-01)

Blood pressure lowering effects of β‐blockers as add‐on or combination therapy: A meta‐analysis of randomized controlled trials
by: Qian‐Hui Guo, et al.
Published: (2023-03-01)

Heart rate is a useful marker of adherence to beta-blocker treatment in hypertension
by: Eva Kociánová, et al.
Published: (2017-09-01)

BLOOD PRESSURE PHENOTYPES IN TREATED HYPERTENSIVE PATIENTS IN SUMMER AND WINTER: FOCUS ON MASKED UNCONTROLLED HYPERTENSION. Part 2. The main markers
by: M. I. Smirnova, et al.
Published: (2017-12-01)

Hypertension Control and Guideline-Recommended Target Blood Pressure Goal Achievement at an Early Stage of Hypertension in the UAE
by: Akshaya Srikanth Bhagavathula, et al.
Published: (2021-12-01)

BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE
by: M. V. Leonova
Published: (2015-12-01)

Repurposing beta-blockers for combinatory cancer treatment: effects on conventional and immune therapies
by: Rachel Massalee, et al.
Published: (2024-01-01)